NASDAQ : CRIS
Curis, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.6 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.46M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Curis, Inc. (CRIS) reported revenue of 4.31M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 4.31M | 9.44M | 10.91M | 10.02M | 10.16M | 10.75M |
| Other Revenue | -100.00K | |||||
| Revenue | 4.31M | 9.44M | 10.91M | 10.02M | 10.16M | 10.65M |
| Cost of Revenue | 25.65M | 28.30M | 38.66M | 39.71M | 43.53M | 35.42M |
| Gross Profit | -21.34M | -18.86M | -27.75M | -29.68M | -33.37M | -24.77M |
| Selling, General & Admin | 14.61M | 14.05M | 16.79M | 18.65M | 19.65M | 17.30M |
| Operating Expenses | 14.61M | 14.05M | 16.79M | 18.65M | 19.65M | 17.30M |
| Operating Income | -35.95M | -32.90M | -44.54M | -48.33M | -53.02M | -42.06M |
| Interest Expense | -1.20M | -2.19M | -615.00K | -2.02M | -4.77M | -4.47M |
| Interest & Investment Income | 270.00K | 316.00K | 1.77M | 2.94M | 1.12M | 211.00K |
| Other Non Operating Income (Expenses) | -11.46M | |||||
| EBT Excluding Unusual Items | -48.34M | -34.77M | -43.39M | -47.41M | -56.67M | -46.33M |
| Gain (Loss) on Sale of Assets | 27.19M | 27.19M | ||||
| Other Unusual Items | 890.00K | |||||
| Pretax Income | -21.15M | -7.58M | -43.39M | -47.41M | -56.67M | -45.44M |
| Net Income | -21.15M | -7.58M | -43.39M | -47.41M | -56.67M | -45.44M |
| Net Income to Common | -21.15M | -7.58M | -43.39M | -47.41M | -56.67M | -45.44M |
| Shares Outstanding (Basic) | 1.95M | 658.20K | 315.31K | 264.67K | 233.48K | 228.92K |
| Shares Outstanding (Diluted) | 1.95M | 658.20K | 315.31K | 264.67K | 233.48K | 228.92K |
| EPS (Basic) | -10.85 | -11.52 | -137.61 | -179.14 | -242.73 | -198.48 |
| EPS (Diluted) | -10.85 | -11.52 | -137.61 | -179.14 | -242.73 | -198.48 |
| Free Cash Flow | -30.59M | -27.20M | -39.56M | -38.43M | -54.75M | -37.62M |
| Free Cash Flow Per Share | -15.69 | -41.33 | -125.47 | -145.22 | -234.51 | -164.33 |
| Gross Margin | -199.68% | -254.42% | -296.17% | -232.59% | ||
| Operating Margin | -833.40% | -348.43% | -408.34% | -482.21% | -521.75% | -395.01% |
| Profit Margin | -490.33% | -80.29% | -397.77% | -473.04% | -557.69% | -426.67% |
| Free Cash Flow Margin | -709.02% | -288.06% | -362.70% | -383.46% | -538.80% | -353.26% |
| EBITDA | -35.87M | -32.73M | -44.34M | -48.08M | -52.79M | -41.91M |
| D&A For EBITDA | 84.00K | 169.00K | 203.00K | 255.00K | 233.00K | 158.00K |
| EBIT | -35.95M | -32.90M | -44.54M | -48.33M | -53.02M | -42.06M |
| Revenue as Reported | 10.65M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.07M | 5.06M | 20.00M | 26.68M | 19.66M | 40.01M |
| Short-Term Investments | 29.65M | 65.97M | 75.87M | |||
| Cash & Short-Term Investments | 5.07M | 5.06M | 20.00M | 56.33M | 85.62M | 115.88M |
| Receivables | 3.35M | 2.79M | 2.98M | 3.22M | ||
| Prepaid Expenses | 1.11M | 1.85M | 3.04M | 1.78M | 3.52M | 3.27M |
| Restricted Cash | 544.00K | |||||
| Total Current Assets | 6.72M | 6.92M | 26.39M | 60.91M | 92.12M | 122.38M |
| Property, Plant & Equipment | 1.25M | 1.95M | 3.39M | 3.49M | 5.09M | 6.25M |
| Long-Term Investments | 23.96M | |||||
| Goodwill | 8.98M | 8.98M | 8.98M | 8.98M | 8.98M | 8.98M |
| Other Long-Term Assets | 2.01M | 2.12M | 2.50M | 3.90M | 2.66M | 726.00K |
| Total Assets | 18.97M | 19.97M | 41.27M | 77.28M | 108.85M | 162.30M |
| Accounts Payable | 5.39M | 5.61M | 3.02M | 3.17M | 3.19M | 6.42M |
| Accrued Expenses | 7.24M | 7.27M | 7.11M | 9.04M | 5.68M | 6.34M |
| Current Portion of Long-Term Debt | 7.56M | 8.50M | ||||
| Current Portion of Leases | 1.04M | 1.19M | 1.34M | 1.30M | 1.14M | 682.00K |
| Total Current Liabilities | 13.68M | 14.08M | 19.03M | 22.02M | 10.01M | 13.44M |
| Long-Term Debt | 26.62M | 34.10M | 49.48M | 53.80M | ||
| Long-Term Leases | 428.00K | 1.62M | 1.49M | 2.80M | 4.36M | |
| Other Long-Term Liabilities | 600.00K | |||||
| Total Liabilities | 14.28M | 14.50M | 47.26M | 57.61M | 62.30M | 71.59M |
| Common Stock | 19.00K | 129.00K | 85.00K | 59.00K | 48.00K | 916.00K |
| Additional Paid-In Capital | 1.28B | 1.25B | 1.23B | 1.22B | 1.20B | 1.18B |
| Retained Earnings | -1.28B | -1.25B | -1.24B | -1.20B | -1.15B | -1.09B |
| Comprehensive Income & Other | 229.00K | -186.00K | -109.00K | |||
| Shareholders' Equity | 4.70M | 5.46M | -6.00M | 19.67M | 46.55M | 90.71M |
| Total Liabilities & Equity | 18.97M | 19.97M | 41.27M | 77.28M | 108.85M | 162.30M |
| Total Debt | 1.04M | 1.62M | 37.13M | 45.40M | 53.42M | 58.84M |
| Net Cash (Debt) | 4.03M | 3.44M | -17.13M | 10.93M | 32.20M | 57.05M |
| Net Cash Per Share | 2.07 | 5.23 | -54.33 | 41.31 | 137.91 | 249.19 |
| Filing Date Shares Outstanding | 2.09M | 2.00M | 424.39K | 294.70K | 241.54K | 229.11K |
| Total Common Shares Outstanding | 1.95M | 646.44K | 424.39K | 294.70K | 241.52K | 229.11K |
| Working Capital | -6.95M | -7.16M | 7.36M | 38.89M | 82.11M | 108.94M |
| Book Value Per Share | 2.41 | 8.45 | -14.13 | 66.74 | 192.75 | 395.91 |
| Tangible Book Value | -4.29M | -3.52M | -14.98M | 10.69M | 37.57M | 81.72M |
| Tangible Book Value Per Share | -2.20 | -5.45 | -35.30 | 36.27 | 155.56 | 356.70 |
| Machinery | 699.00K | 987.00K | 2.17M | 2.89M | 2.52M | |
| Leasehold Improvements | 214.00K | 257.00K | 257.00K | 257.00K | 214.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -21.15M | -7.58M | -43.39M | -47.41M | -56.67M | -45.44M |
| Depreciation & Amortization | 84.00K | 169.00K | 203.00K | 255.00K | 233.00K | 158.00K |
| Loss (Gain) From Sale of Investments | -16.00K | -1.06M | 351.00K | 1.40M | ||
| Stock-Based Compensation | 2.86M | 4.02M | 5.93M | 6.00M | 6.75M | 5.28M |
| Other Operating Activities | -12.63M | -25.56M | 1.43M | 1.00M | 1.82M | -26.00K |
| Change in Accounts Receivable | -1.63M | -1.03M | -555.00K | 181.00K | 249.00K | -181.00K |
| Change in Accounts Payable | 2.12M | 2.55M | -2.08M | 3.34M | -3.88M | 4.96M |
| Change in Other Net Operating Assets | -239.00K | 236.00K | -1.08M | -742.00K | -3.18M | -3.78M |
| Operating Cash Flow | -30.59M | -27.20M | -39.56M | -38.43M | -54.34M | -37.62M |
| Capital Expenditures | -416.00K | |||||
| Investment in Securities | 29.44M | 37.79M | 33.44M | -47.90M | ||
| Other Investing Activities | 2.50M | 2.50M | ||||
| Investing Cash Flow | 2.50M | 2.50M | 29.44M | 37.79M | 33.02M | -47.90M |
| Issuance of Common Stock | 24.59M | 15.35M | 7.22M | 14.12M | 5.84M | 300.00K |
| Other Financing Activities | -1.57M | -5.59M | -3.79M | -6.54M | -4.97M | -4.47M |
| Financing Cash Flow | 23.02M | 9.77M | 3.44M | 7.58M | 867.00K | -4.17M |
| Net Cash Flow | -5.07M | -14.94M | -6.68M | 6.93M | -20.45M | -89.69M |
| Free Cash Flow | -30.59M | -27.20M | -39.56M | -38.43M | -54.75M | -37.62M |
| Free Cash Flow Margin | -709.02% | -288.06% | -362.70% | -383.46% | -538.80% | -353.26% |
| Free Cash Flow Per Share | -15.69 | -41.33 | -125.47 | -145.22 | -234.51 | -164.33 |
| Levered Free Cash Flow | -15.77M | -10.46M | -25.98M | -19.95M | -33.44M | -20.92M |
| Unlevered Free Cash Flow | -15.02M | -9.09M | -25.60M | -18.69M | -30.46M | -18.12M |
| Cash Interest Paid | 732.00K | 1.53M | 461.00K | 2.36M | 4.11M | 4.44M |
| Change in Working Capital | 248.00K | 1.75M | -3.72M | 2.78M | -6.82M | 1.00M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.83M | 12.76M | 25.91M | 75.01M | 53.02M | 436.06M |
| Enterprise Value | -1.20M | 34.31M | 44.30M | 54.45M | 8.80M | 367.51M |
| Last Close Price | 0.60 | 19.74 | 61.20 | 255.00 | 220.00 | 1,904.00 |
| PS Ratio | 0.57 | 1.35 | 2.38 | 7.48 | 5.22 | 40.95 |
| PB Ratio | 0.25 | 2.34 | -4.32 | 3.81 | 1.14 | 4.81 |
| P/TBV Ratio | 7.02 | 1.41 | 5.34 | |||
| EV/Sales Ratio | 3.63 | 4.06 | 5.43 | 0.87 | 34.51 | |
| Debt / Equity Ratio | 0.22 | 0.30 | -6.19 | 2.31 | 1.15 | 0.65 |
| Net Debt / Equity Ratio | -0.86 | -0.63 | -2.86 | -0.56 | -0.69 | -0.63 |
| Net Debt / EBITDA Ratio | 0.11 | 0.10 | -0.39 | 0.23 | 0.61 | 1.36 |
| Net Debt / FCF Ratio | 0.13 | 0.13 | -0.43 | 0.28 | 0.59 | 1.52 |
| Asset Turnover | 0.18 | 0.31 | 0.18 | 0.11 | 0.07 | 0.06 |
| Quick Ratio | 0.37 | 0.36 | 1.23 | 2.69 | 8.85 | 8.86 |
| Current Ratio | 0.49 | 0.49 | 1.39 | 2.77 | 9.20 | 9.11 |
| Return on Equity (ROE) | -634.71% | -143.19% | -82.58% | -41.05% | ||
| Return on Assets (ROA) | -93.23% | -67.17% | -46.97% | -32.46% | -24.44% | -14.34% |
| Return on Capital Employed (ROCE) | -679.00% | -558.60% | -200.30% | -87.50% | -53.60% | -28.30% |
| Earnings Yield | -1,572.90% | -59.41% | -167.47% | -63.21% | -106.89% | -10.42% |
| FCF Yield | -1,241.95% | -213.14% | -152.70% | -51.24% | -103.27% | -8.63% |
| Buyback Yield / Dilution | -348.43% | -108.75% | -19.14% | -13.36% | -1.99% | -88.14% |